Serbia

v. 19 – Q3 2021

Market Executive Summary Earlier requirements (label-based) are on hold, expectation is that Serbia may follow EU.

Following of GS1 standards.

Key Dates 2013/2014: GS1 pilot project for drugs’ traceability

<-- Return to Countries